Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
EMA makes recommendations to manufacturers as it aims to stem drug shortages
3 years ago
Manufacturing
Pfizer shakes up agency roster under new marketing chief
3 years ago
Marketing
AstraZeneca pushes Tagrisso-chemo combo following positive progression-free survival data
3 years ago
The FTC just went after 'bundling' in Amgen's $28B deal. Will it put a chill on future M&A?
3 years ago
FDA approves Allergan's newest hyaluronic acid injectable — with a new delivery system
3 years ago
FDA+
Podcast ad spending rises among pharma companies, as the audio channel booms across industries
3 years ago
Marketing
Post-recall, OTC eye drop maker handed a warning letter from the FDA
3 years ago
Manufacturing
Ipca Laboratories cited for quality issues at India facility that produces API
3 years ago
Manufacturing
FDA signals support for Pfizer’s RSV shot in adcomm docs before crucial vote
3 years ago
FDA+
MarketingRx roundup: Pharma ad boost on YouTube; Merck re-ups lung cancer test social advocacy
3 years ago
Marketing
Diabetes and obesity experts on social media call emerging class of drugs ‘game changers’ — Harris Poll
3 years ago
Marketing
AstraZeneca is leaving the lobbying group PhRMA, third drugmaker to ditch trade group in last five months
3 years ago
Bayer launches 'Seeing Red' campaign to raise awareness for Mirena's use in heavy periods
3 years ago
Marketing
Bayer cuts four programs amid a 'slow start' to the year
3 years ago
Talc claimants look to sue J&J over alleged fraud in bankruptcy case
3 years ago
Law
Moderna goes after Alnylam, filing counterclaims in Spikevax patent suit
3 years ago
Law
New Alzheimer's drugs from Eisai and Lilly: Expectations set at $10B+ in combined sales by 2030
3 years ago
AstraZeneca changes up asthma campaign, moves to highlight control for hard-to-control subtype
3 years ago
Marketing
FDA adcomm backs accelerated approval of Sarepta's Duchenne gene therapy in close vote
3 years ago
R&D
FDA+
ViiV Healthcare spotlights the power of mother and son relationships in new campaign
3 years ago
Marketing
AbbVie sues drug cost savings company over alleged fraudulent use of patient assistance program
3 years ago
Law
GAO: 340B program netted savings and provided benefits for low-income patients
3 years ago
Astellas wins approval for menopause hot flash treatment Veozah
3 years ago
FDA+
Judge triples Eli Lilly's payout in Medicaid rebate case to $183M+
3 years ago
Law
First page
Previous page
126
127
128
129
130
131
132
Next page
Last page